Clinical Trial Update: Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) [NA]

View source ↗

Summary

A completed clinical trial update describing the characterization of circulating tumor cells captured via c-MET (CTC-MET) across multiple cancer indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Colorectal Cancer
• Gastric Cancer
• Met-amplified Solid Tumors
• Non-small Cell Lung Cancer
• Pancreatic Cancer
• Prostate Cancer
• Renal Cell Carcinoma

Snippet

Sponsor: Duke University | Conditions: Prostate Cancer, Renal Cell Carcinoma | NA | Status: COMPLETED